pfizer inc nyse pfe announced monday that it entered into a definitive agreement to acquire trillium therapeutics inc nasdaq tril for an implied equity value of 226 billion or 1850 per share pfizers acquisition of trillium is just the beginning of the company putting money to work in order to eliminate its patent cliff jim cramer said monday on cnbcs squawk on the street cramer expects many acquisitions to follow so that pfizer can eliminate longerterm worry from investors pfizer has endless firepower and the company is going to use it cramer said if its an oncological franchise buy the stock he said every major company believes that is still where you can make the most money trillium has a terrific oncological platform cramer noted trillium is a clinicalstage immunooncology company that is engaged in developing therapies for the treatment of cancer cramer told cnbc that investors should pay close attention to oncological stocks that have been beaten down and are about to start trials see also bitcoin pfizer covid19 vaccine dogecoin nft and disney 5 headlines from weekend you may have missed pfe price action pfizer has traded as high as 5186 and as low as 3280 over a 52week period at last check monday the stock was up 276 at 5028